Similarly, the "first use syndrome" which has been described in patients dialyzed with new cel lulosic membranes, has been ascribed to the acute and vigorous complement activation that is present in a subset of chronic hemodialysis patients33). Although a role for allergic reactions to ethylene oxide has also been described34, 35), recent data from the Center for Disease Control, which reports on such reactions described a 2-fold higher odds ratio (p<0.001) for patients on cellulose-based mem branes than for synthetic membranes which are also sterilized with ethylene oxide (Table 1) . The results of this single center study has recently been confirmed in a multicenter study, with larger number of patients and published in abstract form46).
Preliminary work is also being pursued on the possibility that biocompatibility of the dialysis membrane may impact on the decline of residual renal function. Recent studies have shown that patients who start peritoneal dialysis retain their residual renal function for much longer periods of time than patients starting hemodialysis. The possi bility that this may be due to the bioincompatibility of the dialysis membrane is suggested by animal studies of rats with 5/6 nephrectomy and exposed chronically to dialysis membranes with different biocompatibilities47). Again, such a hypothesis appears to be supported with clinical studies48).
Finally, the biocompatibility of the dialysis mem branes is likely to be an important factor in the differences in mortality between chronic hemo dialysis patients dialyzed with cellulosic membranes and those dialyzed with synthetic membranes.
Based on a large sample of prevalent patients in which adjustments were made for multiple co morbid factors as well as the dose of dialysis, the mortality rate of patients dialyzed with cellulosic membranes was found to be 20% higher than simi lar patients dialyzed with synthetic biocompatible membranes49). The contribution of flux is however a confounding variable.
Biocompatibility is thus an important concern that involves the entire hemodialysis treatment, plays a major role in the well-being of patients and may have short-term and long-term clinical impli cations50 
